Panyam Bhargavi, Anup Naha, Sivakumar Kannan, Annamalai Rama
Panyam Bhargavi, Anup Naha*, Sivakumar Kannan, Annamalai Rama
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India.
Volume - 13,
Issue - 10,
Year - 2020
The objective of the study is to formulate Solid Self Emulsifying Drug Delivery System (SEDDS) for improvement of solubility and dissolution of poorly water-soluble drug Lercanidipine Hydrochloride which has very less water solubility (0.000165mg/mL) and absolute bioavailability of 10%. The Liquid Self Emulsifying Drug Delivery System concentrate was prepared using different oils, surfactants and cosurfactants which were screened based on saturation solubility studies. The SEDDS prepared using oil like peppermint oil, surfactant as propylene glycol, cosurfactant as PEG 400 showed very good self-emulsification property. The prepared SEDDS were subjected for evaluation of various parameters like self-emulsification property, FTIR studies, DSC studies, viscosity, globule size determination, zeta potential determination, robustness to dilution, thermodynamic stability studies. Liquid SEDDS showed good emulsification with globule size 357.2 nm and PDI 0.491. The optimized SEDDS formulation with 20% peppermint oil, 7% propylene glycol surfactant, 63% PEG 400 cosurfactant and 10% drug was used for the preparation of Solid SEDDS following physical adsorbent technique using Avicel PH 101 as an inert solid adsorbent in 1:4 ratio. The prepared solid SEDDS with free-flowing property were compressed as tablets and evaluated for hardness, friability, drug content, disintegration and dissolution studies. The results of our study conclude that the Avicel PH 101 can be used for the preparation of solid SEDDS to improve the solubility and dissolution of poorly water-soluble drug Lercanidipine Hydrochloride.
Cite this article:
Panyam Bhargavi, Anup Naha, Sivakumar Kannan, Annamalai Rama. Development, Evaluation and Optimization of Solid Self Emulsifying Drug Delivery System (s-SEDDS) of Lercanidipine Hydrochloride. Research J. Pharm. and Tech. 2020; 13(10):4931-4940. doi: 10.5958/0974-360X.2020.00866.5
1. Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine. 2010;5(10):1595–616.
2. Boyd BJ. Past and future evolution in colloidal drug delivery systems. Expert Opin Drug Deliv. 2008;5(1):69–85.
3. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine Nanotechnology, Biol Med [Internet]. 2010;6(1):9–24.
4. Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108–109:303–18.
5. Bonacucina G, Cespi M, Misici-Falzi M PG. Colloidal soft matter as drug delivery system. J Pharm Sci. 2009;98(1):1-42.
6. Franceschinis E, Voinovich D, Grassi M, Perissutti B, Filipovic-grcic J, Martinac A, et al. Self-emulsifying pellets prepared by wet granulation in high-shear mixer : influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm. 2005;291:87–97.
7. Campisi B, Chicco D, Vojnovic D, Phan-Tan-Luu R. Experimental design for a pharmaceutical formulation: Optimisation and robustness. J Pharm Biomed Anal. 1998;18(1–2):57–65.
8. Susan A Charman, William N Charman, Mark C Rogge, Terry D wilson FJD and CWP. Self-Emulsifing Drug Delivery Systems: Formulation and BIopharmaeutic Evaluation of an investigational Lipophilic Compound. Vol. 9, Pharmaceutical Research. 1992.
9. Constantinides PP. Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects. Pharm Res. 1995;12(11):1561–72.
10. Wagh MP, Singh PK, Chaudhari CS K DA. Solid self-emulsifying drug delivery system: Preparation techniques and dosage forms. Int J Biopharm [Internet]. 2014;5(2):101–8.
11. Christensen KL, Pedersen GP, Kristensen HG. Technical optimisation of redispersible dry emulsions. Int J Pharm. 2001;212(2):195–202.
12. Hamdani J, Moës AJ, Amighi K. Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm. 2003;260(1):47–57.
13. Shively ML. Characterization of Oil in Water emulsions prepared from solid state emulsions: Effect of matrix and oil phase. Pharm Res. 1993;10(8):1153–6.
14. Agrawal S, Giri TK, Tripathi DK, Alexander A. A review on novel therapeutic strategies for the enhancement of solubility of hydrophobic drugs through lipid and surfactant based SEDDS : A novel approach. Am J Drug Discov Dev. 2012;2(4):143–83.
15. Dv D, Bs P, Pr S. Self Emulsifying Drug Delivery System (Sedds): a Method for Bioavailability Enhancement. Int J Pharm Biol Sci. 2014;4(3):479–94.
16. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–82.
17. Amidon GL, Lennernäs H, Shah VP, Crison JR. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm Res An Off J Am Assoc Pharm Sci. 1995;12(3):413–20.
18. Serajuddln ATM. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88(10):1058–66.
19. Skibic MJ, Taylor KW, Occolowitz JL, Collins MW, Paschal JW, Lorenz LJ, et al. Aqueous acidic degradation of the carbacephalosporin loracarbef. J Pharm Sci. 1993;82(10):1010–7.
20. Bernstein F, Augustine MA, TM Serajuddin, Pai Chang Sheen DM. Effect of ehicle amphiphilicity on the dissolution and bioavailability of a poorly water soluble drug from solid dispersions. J Pharm Sci. 1988;77(5):414–7.
21. GUPTA ROOP N G. Enhancement of Oral Bioavailability of Lipophillic Drugs Fromself-Microemulsifying Drug Delivery System (Smedds). Int J Drug Dev Res. 2009;1(1):10–8.
22. Goli R, Katariya C, Chaudhari S. Formulation and Evaluation of Solid Self Micro Emulsifying Drug Delivery System of Lamotrigine. Am J Pharmtech Res. 2012;2(5):661–79.
23. Agarwal V, Siddiqui A, Ali H, Nazzal S. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int J Pharm. 2009;366(1–2):44–52.
24. Mandawgade SD, Sharma S, Pathak S, Patravale VB. Development of SMEDDS using natural lipophile: Application to β-Artemether delivery. Int J Pharm. 2008;362(1–2):179–83.
25. Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. Oral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluation. Powder Technol [Internet]. 2012; 221:375–82.
26. S. K, V.S.R. CP, S. B. Approaches for the development of solid self-emulsifying drug delivery systems and dosage forms. Asian J Pharm Sci [Internet]. 2009;4(4):240–53.
27. Pathak A, Jain V, Nagariya AK, Singh R, Nayak S, Bansal P, et al. Recent advances in Self emulsifying drug delivery system - a review. Drug Invent Today [Internet]. 2010;2(2):123–9.
28. Dabhi MR, Limbani MD, Sheth NR. Preparation and In Vivo Evaluation of Self-Nanoemulsifying Drug Delivery System (SNEDDS) Containing Ezetimibe. Curr Nanosci. 2011;7:616–27.
29. Burcham DL, Maurin MB, Hausner EA, Huang SM. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm Drug Dispos. 1997;18(8):737–42.
30. Myers RA, Stella VJ. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm. 1992;78(1–3):217–26.
31. Muhannad Jumaaa, Franz H. Furkertb BWM. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm. 2002;53(1):115–23.
32. Schwendener RA, Schott H. Lipophilic 1-β-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. J Cancer Res Clin Oncol. 1996;122(12):723–6.
33. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227–43.
34. Taha E, Samy A, Kassem A, Khan M. Response Surface Methodology for the Development of Self-Nanoemulsified Drug Delivery System (SNEDDS) of All-Trans-Retinol Acetate. Pharm Dev Technol. 2005;10(3):363–70.
35. Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63(3):288–94.
36. Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006; 58:1183–91.
37. Patil P, Joshi P, Paradkar A. Effect of Formulation Variables on Preparation and Evaluation of Gelled Self-emulsifying Drug Delivery System (SEDDS) of Ketoprofen. AAPS PharmSciTech. 2004;5(3):1–8.
38. Tiwari N, Chopra H, Sagar M, Sharma AK. A Review on Self Emulsified Drug Delivery System: A Promising Approach for Drug Delivery of BCS Class II and IV Drugs. J Pharm Res. 2016;15(4):181.
39. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q 10 : formulation development and bioavailability assessment. Int J Pharm. 2001;212:233–46.
40. Palin KJ, Phillips AJ, Ning A. The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm. 1986;33(1–3):99–104.
41. Kararli TT, Needham TE, Griffin M, Schoenhard G, Ferro LJ, Alcorn L. Oral Delivery of a Renin Inhibitor Compound Using Emulsion Formulations. Pharm Res. 1992;9(7):888–93.
42. Nakakuki S. Gastro-Intestinal Absorption of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy) phenyl] propionate from different dosage forms in Rats and Dogs. Chem Pharm Bull. 1986;34 (1):430–3.
43. Wei L, Sun, Peinan NS and WP. Preparation and Evaluation of SEDDS and SMEDDS Containing Carvedilol. Drug Dev Ind Pharm. 2005;31:785–94.
44. Bok Ki Kang, Jin Soo Lee, Se Kang Chon, Sang Young Jeong, Soon Hong Yuk, Gilson Khang HBLSHC. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004; 274:65–73.
45. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J Control Release. 2002;81(1–2):65–74.
46. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179–88.
47. Embleton JK, Pouton CW. Structure and function of gastro-intestinal lipases. Adv Drug Deliv Rev. 1997;25(1):15–32.
48. Cilla DD, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects. Clin Pharmacol Ther. 1996;60(6):687–95.
49. Agoram B, Woltosz WS, Bolger MB. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev. 2001;50(SUPPL. 1).
50. EGGENTON RJCBAJ. MEMBRANE POTENTIALS OF EPITHELIAL CELLS IN RAT SMALL INTESTINE. J Physiol. 1972;227:201–16.
51. Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm. 2003;262(1–2):23–8.
52. Aboofazeli R, Lawrence MJ. Investigations into the formation and characterization of phospholipid microemulsions. II. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and alcohol: influence of purity of lecithin. Int J Pharm. 1994;106(1):51–61.
53. Bachynsky MO, Shah NH, Patel CI, Malick AW. Factors affecting the efficiency of a self-emulsifying oral delivery system. Drug Dev Ind Pharm. 1997;23(8):809–16.
54. Aungst BJ, Rogers NJ, Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther. 1988;244(1):23–7.
55. Wakerly MG, Pouton CW, Meakin BJ, Morton FS. Self-Emulsification of Vegetable Oil-Nonionic Surfactant Mixtures. In: ACS Symposium Series, American Chemical Society. 1986. p. 242–55.
56. Gregory A McClelland, R John Stubbs, Joseph A Fix, Stefano A Pogany GMZ. Enhancement of 3-Hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) Reductase Inhibitor Efficacy Through Administration of a Controlled - Porosity Osmotic Pump Dosage form. Pharm Res. 1991;8(7):873–6.
57. Craig DQM, Lievens HSR, Pitt KG, Storey DE. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm. 1993;96(1–3):147–55.
58. Haiyung Cheng, Steven C Sutton, James D Pipkin, Gaylen M Zentner, J. Douglas Rogers, Jules I Schwartz, Yale B Mitchel, Kenneth Grasing, Michael S Schwartz, Raju D Amin, Lida Liu, David L Ebel, Amy Coulter, Karen Engle, Gregory A McClelland, Chung Y Lui GSR. Evaluation of sustained/controlled release dosage forms of 3-Hydroxy-3-methylglutaryl-COenzyme A(HMG-CoA) Reductase Inhibitors in Dogs and Humans. Pharm Res. 1993;10(11):1683–7.
59. Ji-Yeon Hong, Jin-Ki Kim, Yun-Kyoung Song, Jeong-Sook Park C-KK. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release. 2006; 110:332–8.
60. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water-soluble drugs. Adv Drug Deliv Rev. 1997;25(1):103–28.
61. Six K, Verreck G, Peeters J, Brewster M, Van Den Mooter G. Increased Physical Stability and Improved Dissolution Properties of Itraconazole, a Class II Drug, by Solid Dispersions that Combine Fast- and Slow-Dissolving Polymers. J Pharm Sci. 2004;93(1):124–31.
62. O’Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci. 2002;15(5):405–15.
63. Kislalioglu MS, Khan MA, Blount C, Goettsch RW, Bolton S. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates. J Pharm Sci. 1991;80(8):799–804.
64. Moyano JR, Arias MJ, Ginés JM, Pérez JI, Rabasco AM. Dissolution behavior of oxazepam in presence of cyclodextrins: Evaluation of oxazepam - DIMEB binary system. Drug Dev Ind Pharm. 1997;23(4):379–85.
65. Gang Soo Chae, Jin Soo Lee, Seon Hwa Kim, Kwang Su Seo, Moon Suk Kim, Hai Bang Lee GK. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer. Int J Pharm. 2005;301:6–14.
66. Holm R, Porter CJH, Edwards GA, Müllertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci. 2003;20(1):91–7.
67. Wang CH, Li J, Teo CS, Lee T. The delivery of BCNU to brain tumors. J Control Release. 1999;61(1–2):21–41.
68. Tuleu C, Newton M, Rose J, Euler D, Saklatvala R, Clarke A, et al. Comparative bioavailability study in dogs of self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004;93(6):1495–502.
69. BD Tarr, TG Sambandan SYa. A new parenteral emulsion for the administration of taxol. Pharm Res. 1987;4(2):162–5.
70. Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 1995; 114:103–10.
71. Alany RG, Wen J. Microemulsions as Drug Delivery Systems. Pharm Manuf Handb Prod Process. 2007;3(4):769–92.
72. Gao ZG, Choi HG, Shin HJ, Park KM, Lim SJ, Hwang KJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm. 1998;161(1):75–86.
73. Hauss DJ, Fogal SE, Ficorilli J V., Price CA, Roy T, Jayaraj AA, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci. 1998;87(2):164–9.
74. Kiela PR, Ghishan FK. Physiology of intestinal absorption and secretion. Best Pract Res Clin Gastroenterol [Internet]. 2016;30(2):145–59.
75. Levy MY, Benita S. Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model. Int J Pharm. 1990;66(1–3):29–37.
76. Nerurker MM, Burton PS, Borchardt RT. The use of Surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Vol. 13, Pharmaceutical research. 1996.
77. Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res. 1999;16(12):1812–7.
78. Leichner C, Baus RA, Jelkmann M, Plautz M, Barthelmes J, Dünnhaupt S, et al. In vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for nasal administration of dimenhydrinate. Drug Deliv Transl Res. 2019;9(5):945–55.
79. Armstrong NA, James KC. Drug release from lipid-based dosage forms. II. Int J Pharm. 1980;6(3–4):195–204.
80. Kamel R, Basha M. Preparation and in vitro evaluation of rutin nanostructured liquisolid delivery system. Bull Fac Pharmacy, Cairo Univ [Internet]. 2013;51(2):261–72.
81. Saifee M, Zarekar S, Rao VU, Zaheer Z, Soni R, Burande S. Formulation and in vitro evaluation of solid-self-emulsifying drug delivery system (SEDDS) of glibenclamide. Am J Adv Drug Deliv [Internet]. 2013;1(3):323–40, 18 pp.
82. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994; 106:15–23.